User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    Peptide receptor radionuclide therapy.
    Krenning, Eric P Kwekkeboom, Dik J Valkema, Roelf Pauwels, Stanislas[UCL] Kvols, Larry K De Jong, Marion (2004) Annals of the New York Academy of Sciences — Vol. 1014, p. 234-45 (2004)
    • Journal article
    Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
    Barone, Raffaella[UCL] Pauwels, Stanislas[UCL] De Camps, Joëlle[UCL] Krenning, Eric P Kvols, Larry K Smith, M Charles Bouterfa, Hakim Devuyst, Olivier[UCL] Jamar, François[UCL] (2004) Nephrology, Dialysis, Transplantation — Vol. 19, no. 9, p. 2275-2281 (2004)
    • Journal article
    Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.
    Helisch, Andreas Förster, Gregor J Reber, Helmut Buchholz, Hans-Georg Arnold, Rudolf Göke, Burkhard Weber, Matthias M Wiedenmann, Bertram Pauwels, Stanislas[UCL] Haus, Ulrike Bouterfa, Hakim Bartenstein, Peter (2004) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 31, no. 10, p. 1386-1392 (2004)
    • Speech
    Endocytosis of radiolabelled somatostatin analogues by the OK cell line, as an in vitro model to assess their mechanism of kidney uptake
    Barone, Raffaella[UCL] Devuyst, Olivier[UCL] Pauwels, Stanislas[UCL] Jamar, François[UCL] Courtoy, Pierre J.[UCL] Van Der Smissen, Patrick[UCL] Beaujean, Viviane[UCL] (2004) Annual Congress of the European-Association-of-Nuclear-Medicine — Helsinki (Finland)
    • Speech
    Peptide receptor radiotherapy (PRRT) with [Y-90-DOTA,Tyr3]octreotide: Toxicity and efficacy of 4-cycle and single-cycle regimens
    Valkema, R Pauwels, Stanislas[UCL] Jamar, François[UCL] Kvols, LK Barone, Raffaella[UCL] Lasher, J Krenning, EP (2004) 40th Annual Meeting of the American-Society-of-Clinical-Oncology — New Orleans (La)